PDF herunterladen
Planta Med 2016; 82(14): 1236-1245
DOI: 10.1055/s-0042-110496
Reviews
Georg Thieme Verlag KG Stuttgart · New York

A Review of the Medicinal Uses and Pharmacology of Ashitaba

Lindsay K. Caesar
Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, NC, USA
,
Nadja B. Cech
Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, NC, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 09. Mai 2016
revised 01. Juni 2016

accepted 09. Juni 2016

Publikationsdatum:
11. Juli 2016 (online)

Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Angelica keiskei Koidzumi, or ashitaba, is a popular botanical medicine in Japan containing diverse bioactive components including prenylated chalcones, linear and angular coumarins, and flavanones. This review provides an overview of the current knowledge of ashitaba metabolites and their biological activities to prioritize future studies. Ashitaba is purported to possess cytotoxic, antidiabetic, antioxidative, anti-inflammatory, antihypertensive, and antimicrobial properties. Although many in vitro studies have been conducted on ashitabaʼs chemical constituents, the in vivo efficacy and clinical relevance of this plant has yet to be confirmed for most of these activities. Here we describe the chemical composition of ashitaba and present the pharmacological effects of this botanical as supported by the current literature. The experimental results demonstrate promise for the medical use of ashitaba, but considerable work needs to be done to understand the mechanisms of action of its metabolites. Additionally, in vivo and clinical trials as well as additional studies on less abundant bioactive compounds are warranted.

Key words

Angelica keiskei - Apiaceae - bioactivity studies - coumarins - prenylated chalcones
 

  • References

  • 1 Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the Use of complementary Health approaches among Adults: United States, 2002 – 2012. National Health Statistics Report, No. 79. Hyattsville, MD: National Center for Health Statistics; 2015
    Suche in Google Scholar
  • 2 Sarkar SD, Nahar L. Natural medicine: the genus Angelica . Curr Med Chem 2004; 11: 1479-1500
    CrossrefPubMedSuche in Google Scholar
  • 3 Akihisa T, Tokuda H, Hasegawa D, Ukiya M, Kimura Y, Enjo F, Suzuki T, Nishino H. Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J Nat Prod 2006; 29: 38-42
    PubMedSuche in Google Scholar
  • 4 Kim DW, Curtis-Long MJ, Yuk HR, Wang Y, Song YH, Jeong SH, Park KH. Quantitative analysis of phenolic metabolites from different parts of Angelica keiskei by HPLC-ESI MS/MS and their xanthine oxidase inhibition. Food Chem 2014; 153: 20-27
    CrossrefPubMedSuche in Google Scholar
  • 5 Winkel-Shirley B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 2011; 126: 485-493
    PubMedSuche in Google Scholar
  • 6 Zhang H, Liu JJ, Sun J, Yang XH, Zhao TT, Lu X, Gong HB, Zhu HL. Design, synthesis, and biological evaluation of novel chalcone derivatives as antitubulin agents. Bioorg Med Chem 2012; 20: 3212-3218
    CrossrefPubMedSuche in Google Scholar
  • 7 Mahapatra DK, Asati V, Bharti SK. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives. Eur J Med Chem 2015; 92: 839-865
    CrossrefPubMedSuche in Google Scholar
  • 8 Battenberg OA, Yang Y, Verhelst SH, Sieber SA. Target profiling of 4-hydroxyderricin in S. aureus reveals seryl-tRNA synthetase binding and inhibition by covalent modification. Mol Biosyst 2013; 9: 343-351
    CrossrefPubMedSuche in Google Scholar
  • 9 Yadav VR, Prasad S, Sung B, Aggarwal BB. The role of chalcones in suppression of NF-κB-mediated inflammation and cancer. Int Immunopharmacol 2011; 11: 295-309
    CrossrefPubMedSuche in Google Scholar
  • 10 Ceremuga TE, Johnson LA, Adams-Henderson J, McCall S, Johnson D. Investigation of the anxiolytic effects of xanthohumol, a component of Humulus lupulus (Hops), in the male Sprague-Dawley rat. AANA J 2013; 81: 193-198
    PubMedSuche in Google Scholar
  • 11 Zhou B, Xing C. Diverse molecular targets for chalcones with varied bioactivities. Med Chem 2015; 5: 388-404
    PubMedSuche in Google Scholar
  • 12 Zhang T, Yamashita Y, Yasuda M, Yamamoto N, Ashida H. Ashitaba (Angelica keiskei) extract prevents adiposity in high-fat diet-fed C57BL/6 mice. Food Funct 2015; 6: 135-145
    PubMedSuche in Google Scholar
  • 13 Bourgaud F, Hehn A, Larbat R, Doerper S, Gontier E, Kellner S, Matern U. Biosynthesis of coumarins in plants: a major pathway still to be unravelled for cytochrome P450 enzymes. Phytochem Rev 2006; 5: 293-308
    CrossrefPubMedSuche in Google Scholar
  • 14 Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 2004; 10: 3813-3833
    CrossrefPubMedSuche in Google Scholar
  • 15 Musa MA, Cooperwood JS, Khan MO. A review of coumarin derivatives in pharmacotherapy of breast cancer. Curr Med Chem 2008; 15: 2664-2679
    CrossrefPubMedSuche in Google Scholar
  • 16 Okuyama T, Takata M, Takayasu J, Hasegawa T, Tokuda H, Nishino A, Nishino H, Iwashima A. Anti-tumor-promotion by principles obtained from Angelica keiskei . Planta Med 1991; 57: 242-246
    Thieme ConnectPubMedSuche in Google Scholar
  • 17 Akihisa T, Tokuda H, Ukiya M, Iizuka M, Schneider S, Ogasawara K, Mukainaka T, Iwatsuki K, Suzuki T, Nishino H. Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects. Cancer Lett 2003; 201: 133-137
    CrossrefPubMedSuche in Google Scholar
  • 18 Li J, Gao L, Meng F, Tang CL, Zhang RJ, Li JY, Luo C, Li J, Zhao WM. PTP1B inhibitors from stems of Angelica keiskei (Ashitaba). Bioorg Med Chem Lett 2015; 25: 2028-2032
    CrossrefPubMedSuche in Google Scholar
  • 19 Ogawa H, Nakamura R, Baba K. Beneficial effect of laserpitin, a coumarin compound from Angelica keiskei, on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2005; 32: 1104-1109
    CrossrefPubMedSuche in Google Scholar
  • 20 Wong E. The role of chalcones and flavanones in flavonoid biosynthesis. Phytochemistry 1968; 7: 1751-1758
    CrossrefPubMedSuche in Google Scholar
  • 21 Khan MK, Zill EH, Dangles O. A comprehensive review on flavanones, the major citrus polyphenols. J Food Comp Anal 2014; 33: 85-104
    CrossrefPubMedSuche in Google Scholar
  • 22 Aoki N, Ohta S. Ashitabaol A, a new antioxidative sesquiterpenoid from seeds of Angelica keiskei . Tetrahedron Lett 2010; 51: 3449-3450
    CrossrefPubMedSuche in Google Scholar
  • 23 Enoki T, Ohnogi H, Nagamine K, Kudo Y, Sugiyama K, Tanabe M, Kobayashi K, Sagawa H, Kato I. Antidiabetic activities of chalcones isolated from a Japanese herb, Angelica keiskei . J Agric Food Chem 2007; 55: 6013-6017
    CrossrefPubMedSuche in Google Scholar
  • 24 Luo L, Wang R, Wang X, Ma Z, Li N. Compounds from Angelica keiskei with NQO1 induction, DPPH scavenging and α-glucosidase inhibitory activities. Food Chem 2012; 131: 992-998
    CrossrefPubMedSuche in Google Scholar
  • 25 Kawabata K, Sawada K, Ikeda K, Fukuda I, Kawasaki K, Yamamoto N, Ashida H. Prenylated chalcones 4-hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation. Mol Nutr Food Res 2011; 55: 467-475
    CrossrefPubMedSuche in Google Scholar
  • 26 Zhang T, Sawada K, Yamamoto N, Ashida H. 4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppress differentiation of preadipocytes to adipocytes via AMPK and MAPK pathways. Mol Nutr Food Res 2013; 57: 1729-1740
    PubMedSuche in Google Scholar
  • 27 Ohnogi H, Kudo Y, Tahara K, Sugiyama K, Enoki T, Hayami S, Sagawa H, Tanimura Y, Aoi W, Naito Y, Kato I, Yoshikawa T. Six new chalcones from Angelica keiskei inducing adiponectin production in 3T3-L1 adipocytes. Biosci Biotechnol Biochem 2012; 76: 961-966
    CrossrefPubMedSuche in Google Scholar
  • 28 Ohnogi H, Hayami S, Kudo Y, Enoki T. Efficacy and safety of ashitaba (Angelica keiskei) on the patients and candidates with metabolic syndrome: a pilot study. JJCAM 2012; 9: 49-55
    CrossrefPubMedSuche in Google Scholar
  • 29 Hashimoto K, Kawamata S, Usui N, Tanaka A, Uda Y. In vitro induction of the anticarcinogenic marker enzyme, quinone reductase, in human hepatoma cells by food extracts. Cancer Lett 2002; 180: 1-5
    CrossrefPubMedSuche in Google Scholar
  • 30 Akihisa T, Motoi T, Seki A, Kikuchi T, Fukatsu M, Tokuda H, Suzuki N, Kimura Y. Cytotoxic activities and anti-tumor-promoting effects of microbial transformation products of prenylated chalcones from Angelica keiskei . Chem Biodivers 2012; 9: 318-330
    CrossrefPubMedSuche in Google Scholar
  • 31 Aoki N, Muko M, Ohta E, Ohta S. C-Geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. J Nat Prod 2008; 71: 1308-1310
    CrossrefPubMedSuche in Google Scholar
  • 32 Yasuda M, Kawabata K, Miyashita M, Okumura M, Yamamoto N, Takahashi M, Ashida H, Ohigashi H. Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophages. J Agric Food Chem 2014; 62: 462-467
    CrossrefPubMedSuche in Google Scholar
  • 33 Sugii M, Ohkita M, Taniguchi M, Baba K, Kawai Y, Tahara C, Takaoka M, Matsumura Y. Xanthoangelol D isolated from the roots of Angelica keiskei inhibits endothelin-1 production through the suppression of nuclear factor kappaB. Biol Pharm Bull 2005; 28: 607-610
    CrossrefPubMedSuche in Google Scholar
  • 34 Lee HJ, Choi TW, Kim HJ, Nam D, Jung SH, Lee EH, Lee HJ, Shin EM, Jang HJ, Ahn KS, Shim BS, Choi SH, Kim SH, Sethi G, Ahn KS. Anti-inflammatory activity of Angelica keiskei through suppression of mitogen-activated protein kinases and nuclear factor κB activation pathways. J Med Food 2010; 13: 691-699
    CrossrefPubMedSuche in Google Scholar
  • 35 Ohkura N, Nakakuki Y, Taniguchi M, Kanai S, Nakayama A, Ohnishi K, Sakata T, Nohira T, Matsuda J, Baba K, Atsumi G. Xanthoangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production. Biofactors 2011; 37: 455-461
    CrossrefPubMedSuche in Google Scholar
  • 36 Nakata K, Baba K. Histamine release inhibition activity of Angelica keiskei . Nat Med 2001; 55: 32-34
    PubMedSuche in Google Scholar
  • 37 Son DJ, Park YO, Yu C, Lee SE, Park YH. Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.). Nat Prod Res 2014; 28: 2312-2316
    CrossrefPubMedSuche in Google Scholar
  • 38 Shimizu E, Hayashi A, Takahashi R, Aoyagi Y, Murakami T, Kimoto K. Effects of angiotensin I-converting enzyme inhibitor from ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats. J Nutr Sci Vitaminol 1999; 45: 375-383
    CrossrefPubMedSuche in Google Scholar
  • 39 Park JY, Jeong HJ, Kim YM, Park SJ, Rho MC, Park KH, Ryu YB, Lee WS. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition. Bioorg Med Chem Lett 2011; 21: 5602-5604
    CrossrefPubMedSuche in Google Scholar
  • 40 Inamori K, Baba K, Tsujibo H, Taniguchi M, Nakata K, Kozawa M. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated form the root of Angelica keiskei KOIDZUMI. Chem Pharm Bull 1991; 39: 1604-1605
    CrossrefPubMedSuche in Google Scholar
  • 41 Wesolowska O, Gasiorowska J, Petrus J, Czarnik-Matusewicz B, Michalak K. Interaction of prenylated chacones and flavaonones from common hop with phosphatidylcholine model membranes. Biochim Biophys Acta 2014; 1838: 173-184
    CrossrefPubMedSuche in Google Scholar
  • 42 Bolca S, Li J, Nikolic D, Roche N, Blondeel P, Possemiers S, De Keukeleire D, Bracke M, Heyerick A, van Breemen RB, Depypere H. Disposition of hop prenylflavnoids in human breast tissue. Mol Nutr Food Res 2010; 54 (Suppl. 02) S284-S294
    CrossrefPubMedSuche in Google Scholar
  • 43 Hanske L, Loh G, Sczensky S, Blaut M, Braune A. Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol Nutr Food Res 2010; 52: 1405-1413
    PubMedSuche in Google Scholar
  • 44 Possemiers S, Heyerick A, Robbens V, De Keukeleire D, Verstraete W. Activation of proestrogens from hops (Humulus lupulus) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem 2005; 53: 6281-6288
    CrossrefPubMedSuche in Google Scholar
  • 45 Maronpot RR. Toxicological assessment of Ashitaba Chalcone. Food Chem Toxicol 2015; 77: 111-119
    CrossrefPubMedSuche in Google Scholar
  • 46 Son H, Yoon E, Cha Y, Kim MA, Shin YK, Kim JM, Choi YH, Lee SH. Comparison of the toxicity of aqueous and ethanol fractions of Angelica keiskei leaf using the eye irritancy test. Exp Ther Med 2012; 4: 820-824
    PubMedSuche in Google Scholar
  • 47 Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmannʼs disease). Orphanet J Rare Dis 2008; 3: 1-8
    CrossrefPubMedSuche in Google Scholar
  • 48 Messer A, Raquet N, Lohr C, Schrenk D. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity. Food Chem Toxicol 2012; 50: 756-760
    CrossrefPubMedSuche in Google Scholar
  • 49 Eisenbrand G. Toxicological assessment of furocoumarins in foodstuffs, opinion of the Senate Commission on Food Safety of the German Research Foundation–shortened version. Mol Nutr Food Res 2007; 51: 367-373
    CrossrefPubMedSuche in Google Scholar
  • 50 Kozawa M, Morita N, Baba K, Hata K. The structure of xanthoangelol, a new chalcone from the roots of Angelica keiskei Koidzumi (Umbelliferae). Chem Pharm Bull 1977; 25: 515-516
    CrossrefPubMedSuche in Google Scholar
  • 51 Baba K, Nakata K, Taniguchi M, Kido T, Kozawa M. Chalcones from Angelica keiskei . Phytochemistry 1990; 29: 3907-3910
    CrossrefPubMedSuche in Google Scholar
  • 52 Nakata K, Taniguchi K, Baba K. Three chalcones from Angelica keiskei . Nat Med 1999; 53: 329-332
    PubMedSuche in Google Scholar
  • 53 Baba K, Kido T, Yoneda Y, Taniguchi M, Kozawa M. Chemical components of Angelica keiskei Koidzumi v. components of the fruits and comparison of coumarins and chalcones in the fruits roots and leaves. Shoyakugaku Zasshi 1990; 44: 235-239
    PubMedSuche in Google Scholar
  • 54 Ogawa H, Nakashima S, Baba K. Effects of dietary Angelica keiskei on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003; 30: 284-288
    CrossrefPubMedSuche in Google Scholar
  • 55 Kim E, Choi J, Yeo I. The effects of Angelica keiskei Koidz on the expression of antioxidant enzymes related to lipid profiles in rats fed a high fat diet. Nut Res Pract 2012; 6: 9-15
    PubMedSuche in Google Scholar
  • 56 Nagata J, Morino T, Saito M. Effects of dietary Angelica keiskei on serum and liver lipid profiles, and body fat accumulations in rats. J Nutr Sci Vitaminol 2007; 53: 133-137
    CrossrefPubMedSuche in Google Scholar
  • 57 Ohnogi H, Hayami S, Kudo Y, Deguchi S, Mizutani S, Enoki T, Tanimura Y, Aoi W, Naito Y, Kato I, Yoshikawa T. Angelica keiskei extract improves insulin resistance and hypertriglyceridemia in rats fed a high-fructose drink. Biosci Biotechnol Biochem 2012; 96: 928-932
    PubMedSuche in Google Scholar